arrow_back Back to App

More Prescription Drug Plan Choices for Medicare-Only PACE Enrollees

This act allows individuals enrolled in Medicare-only PACE programs to choose a standalone prescription drug plan. This means they can select a drug plan outside of their PACE program's offering, potentially impacting their costs and access to medications. PACE programs will be required to inform and assist enrollees with this new option.
Key points
Medicare-only PACE enrollees can choose a standalone prescription drug plan starting January 1, 2025.
The chosen plan must have estimated out-of-pocket costs and federal subsidies equal to or less than the PACE program's drug plan.
PACE programs must provide information and assistance for choosing these plans, and monitor drug utilization and spending.
Enrollees can switch plans during the year if medications change or out-of-pocket costs unexpectedly increase.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 118_HR_3549
Sponsor: Rep. Wenstrup, Brad R. [R-OH-2]
Process start date: 2023-05-18
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

PACE Part D Choice Act of 2023

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 118_HR_3549.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2023-05-18.

What are the main provisions?

Key points include:

  • Medicare-only PACE enrollees can choose a standalone prescription drug plan starting January 1, 2025.
  • The chosen plan must have estimated out-of-pocket costs and federal subsidies equal to or less than the PACE program's drug plan.
  • PACE programs must provide information and assistance for choosing these plans, and monitor drug utilization and spending.
  • Enrollees can switch plans during the year if medications change or out-of-pocket costs unexpectedly increase.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Wenstrup, Brad R. [R-OH-2].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Health.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-25.

CATEGORIES

Health Benefits